# Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant

> **NCT00964821** · — · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 459 (actual)

## Conditions studied

- Chronic Myeloproliferative Disorders
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasms
- Nonmalignant Neoplasm

## Interventions

- **BIOLOGICAL:** trivalent influenza vaccine
- **OTHER:** Immunoenzyme technique
- **OTHER:** Laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00964821
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 459 (ACTUAL)
- **Last updated:** 2017-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00964821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00964821, "Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00964821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*